Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Revenue	$ 0	$ 0
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	1,105,004	2,183,269
Depreciation	245,996	165,791
Research and development (including stock-based compensation (Note 8))	66,558	48,606
Total operating expenses	1,417,558	2,397,666
Loss from operations	(1,417,558)	(2,397,666)
Interest expense	86,111	55,266
Other expense	1,918
	88,029	55,266
Net loss	(1,505,587)	(2,452,932)
Net loss attributable to the noncontrolling interest	1,294	1,398
Net loss attributable to Bion	(1,504,293)	(2,451,534)
Dividends on preferred stock	(500)	(1,667)
Net loss applicable to Bion's common stockholders	$ (1,504,793)	$ (2,453,201)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.08)	$ (0.14)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	18,055,025	16,927,270